Substrate uptake and metabolism are preserved in hypertrophic caveolin-3 knockout hearts

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 295, Issue 2, 2008, Pages

  Augustus, Ayanna S ^a   Buchanan, Jonathan ^d   Addya, Sankar ^a   Rengo, Giuseppe ^a   Pestell, Richard G ^a   Fortina, Paolo ^a,b   Koch, Walter J ^a   Bensadoun, Andre ^c   Abel, E Dale ^d   Lisanti, Michael P ^a,e,f  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

^c Department of Obstetrics Gynecology   (United States)

^d UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF GENOA   (Italy)

^f G GASLINI INSTITUTE   (Italy)

Author keywords

Adenosine 3 ,5 cyclic monophosphate; Cardiomyopathy; Caveolae; Fatty acids; Isolated perfused hearts

Indexed keywords

CARNITINE PALMITOYLTRANSFERASE; CAVEOLIN 3; CD36 ANTIGEN; FATTY ACID; GLUCOSE; INSULIN RECEPTOR; MESSENGER RNA; RAB PROTEIN; RAB4A PROTEIN; STEROID HORMONE; TESTOSTERONE 17BETA DEHYDROGENASE; UNCLASSIFIED DRUG; CAV3 PROTEIN, MOUSE; CD45 ANTIGEN; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; PTPRC PROTEIN, MOUSE; RETINOL;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DNA MICROARRAY; ENZYME INACTIVATION; ENZYME SUBSTRATE; ENZYME SUBSTRATE COMPLEX; GENE EXPRESSION REGULATION; GENE TARGETING; HEART HYPERTROPHY; HEART MUSCLE CONTRACTILITY; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN METABOLISM; REAL TIME POLYMERASE CHAIN REACTION; ANIMAL; C57BL MOUSE; CARDIOMEGALY; ECHOGRAPHY; ENDOCYTOSIS; ENERGY METABOLISM; ENZYMOLOGY; FIBROSIS; GENE EXPRESSION PROFILING; GENETICS; HEART MUSCLE; INNATE IMMUNITY; LIPID METABOLISM; MALE; METABOLISM; METHODOLOGY; MOUSE MUTANT; PATHOLOGY; POLYMERASE CHAIN REACTION; TRANSPORT AT THE CELLULAR LEVEL;

ANIMALS; ANTIGENS, CD45; BIOLOGICAL TRANSPORT; CARDIOMEGALY; CAVEOLIN 3; CYCLIC AMP; CYCLIC AMP-DEPENDENT PROTEIN KINASES; ENDOCYTOSIS; ENERGY METABOLISM; FATTY ACIDS; FIBROSIS; GENE EXPRESSION PROFILING; GLUCOSE; IMMUNITY, NATURAL; LIPID METABOLISM; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MYOCARDIUM; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; POLYMERASE CHAIN REACTION; RNA, MESSENGER; VITAMIN A;

EID: 52449117451     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.00387.2008     Document Type: Article

References (52)

1. Allard MF. Energy substrate metabolism in cardiac hypertrophy. Curr Hypertens Rep 6: 430-435, 2004.
2. Augustus AS, Kako Y, Yagyu H, Goldberg IJ. Routes of FA delivery to cardiac muscle: modulation of lipoprotein lipolysis alters uptake of TG-derived FA. Am J Physiol Endocrinol Metab 284: E331-E339, 2003.
3. Aukrust P, Damas JK, Gullestad L, Froland SS. Chemokines in myocardial failure - pathogenic importance and potential therapeutic targets. Clin Exp Immunol 124: 343-345, 2001.
4. Barger PM, Kelly DP. Fatty acid utilization in the hypertrophied and failing heart: molecular regulatory mechanisms. Am J Med Sci 318: 36-42, 1999.
5. Behr TM, Wang X, Aiyar N, Coatney RW, Li X, Koster P, Angermann CE, Ohlstein E, Feuerstein GZ, Winaver J. Monocyte chemoattractant protein-1 is upregulated in rats with volume-overload congestive heart failure. Circulation 102: 1315-1322, 2000.
6. Boren J, Veniant MM, Young SG. Apo B100-containing lipoproteins are secreted by the heart. J Clin Invest 101: 1197-1202, 1998.
7. Buchanan J, Mazumder PK, Hu P, Chakrabarti G, Roberts MW, Yun UJ, Cooksey RC, Litwin SE, Abel ED. Reduced cardiac efficiency and altered substrate metabolism precedes the onset of hyperglycemia and contractile dysfunction in two mouse models of insulin resistance and obesity. Endocrinology 146: 5341-5349, 2005.
8. Bueno OF, De Windt LJ, Tymitz KM, Witt SA, Kimball TR, Klevitsky R, Hewett TE, Jones SP, Lefer DJ, Peng CF, Kitsis RN, Molkentin JD. The MEK1-ERK1/2 signaling pathway promotes compensated cardiac hypertrophy in transgenic mice. EMBO J 19: 6341-6350, 2000.
9. Capozza F, Combs TP, Cohen AW, Cho YR, Park SY, Schubert W, Williams TM, Brasaemle DM, Jelicks LA, Scherer PE, Kim JK, Lisanti MP. Caveolin-3 knockout mice show increased adiposity and whole body insulin resistance, with ligand-induced insulin receptor instability in skeletal muscle. Am J Physiol Cell Physiol 288: C1317-C1331, 2005.
10. Coburn CT, Knapp FF Jr, Febbraio M, Beets AL, Silverstein RL, Abumrad NA. Defective uptake and utilization of long chain fatty acids in muscle and adipose tissues of CD36 knockout mice. J Biol Chem 275: 32523-32529, 2000.
11. Damas JK, Gullestad L, Ueland T, Solum NO, Simonsen S, Froland SS, Aukrust P. CXC-chemokines, a new group of cytokines in congestive heart failure - possible role of platelets and monocytes. Cardiovasc Res 45: 428-436, 2000.
12. Daro E, van der Sluijs P, Galli T, Mellman I. Rab4 and cellubrevin define different early endosome populations on the pathway of transferrin receptor recycling. Proc Natl Acad Sci USA 93: 9559-9564, 1996.
13. Degens H, de Brouwer KF, Gilde AJ, Lindhout M, Willemsen PH, Janssen BJ, van der Vusse GJ, van Bilsen M. Cardiac fatty acid metabolism is preserved in the compensated hypertrophic rat heart. Basic Res Cardiol 101: 17-26, 2006.
14. DeGeorge BR Jr, Gao E, Boucher M, Vinge LE, Martini JS, Raake PW, Chuprun JK, Harris DM, Kim GW, Soltys S, Eckhart AD, Koch WJ. Targeted inhibition of cardiomyocyte Gi signaling enhances susceptibility to apoptotic cell death in response to ischemic stress. Circulation 117: 1378-1387, 2008.
15. Fecchi K, Volonte D, Hezel MP, Schmeck K, Galbiati F. Spatial and temporal regulation of GLUT4 translocation by flotillin-1 and caveolin-3 in skeletal muscle cells. FASEB J 20: 705-707, 2006.
16. Feron O, Belhassen L, Kobzik L, Smith TW, Kelly RA, Michel T. Endothelial nitric oxide synthase targeting to caveolae. Specific interactions with caveolin isoforms in cardiac myocytes and endothelial cells. J Biol Chem 271: 22810-22814, 1996.
17. Folch J, Lees M, Sloane Stanley GH. A simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem 226: 497-509, 1957.
18. Freerksen DL, Schroedl NA, Johnson GV, Hartzell CR. Increased aerobic glucose oxidation by cAMP in cultured regenerated skeletal myotubes. Am J Physiol Cell Physiol 250: C713-C719, 1986.
19. Fritzius T, Burkard G, Haas E, Heinrich J, Schweneker M, Bosse M, Zimmermann S, Frey AD, Caelers A, Bachmann AS, Moelling K. A WD-FYVE protein binds to the kinases Akt and PKCzeta/lambda. Biochem J 399: 9-20, 2006.
20. Fritzius T, Frey AD, Schweneker M, Mayer D, Moelling K. WD-repeat-propeller-FYVE protein, ProF, binds VAMP2 and protein kinase Czeta. FEBS J 274: 1552-1566, 2007.
21. Galbiati F, Engelman JA, Volonte D, Zhang XL, Minetti C, Li M, Hou H Jr, Kneitz B, Edelmann W, Lisanti MP. Caveolin-3 null mice show a loss of caveolae, changes in the microdomain distribution of the dystrophin-glycoprotein complex, and T-tubule abnormalities. J Biol Chem 276: 21425-21433, 2001.
22. Goldberg IJ. Lipoprotein lipase and lipolysis: central roles in lipoprotein metabolism and atherogenesis. J Lipid Res 37: 693-707, 1996.
23. Gustavsson J, Parpal S, Karlsson M, Ramsing C, Thorn H, Borg M, Lindroth M, Peterson KH, Magnusson KE, Stralfors P. Localization of the insulin receptor in caveolae of adipocyte plasma membrane. FASEB J 13: 1961-1971, 1999.
24. Hajri T, Ibrahimi A, Coburn CT, Knapp FF Jr, Kurtz T, Pravenec M, Abumrad NA. Defective fatty acid uptake in the spontaneously hypertensive rat is a primary determinant of altered glucose metabolism, hyperinsulinemia, and myocardial hypertrophy. J Biol Chem 276: 23661-23666, 2001.
25. Haudek SB, Xia Y, Huebener P, Lee JM, Carlson S, Crawford JR, Pilling D, Gomer RH, Trial J, Frangogiannis NG, Entman ML. Bone marrow-derived fibroblast precursors mediate ischemic cardiomyopathy in mice. Proc Natl Acad Sci USA 103: 18284-18289, 2006.
26. Henley JR, Krueger EW, Oswald BJ, McNiven MA. Dynamin-mediated internalization of caveolae. J Cell Biol 141: 85-99, 1998.
27. Hocquette JF, Graulet B, Olivecrona T. Lipoprotein lipase activity and mRNA levels in bovine tissues. Comp Biochem Physiol B Biochem Mol Biol 121: 201-212, 1998.
28. Hodgkinson CP, Mander A, Sale GJ. Protein kinase-zeta interacts with munc18c: role in GLUT4 trafficking. Diabetologia 48: 1627-1636, 2005.
29. Iemitsu M, Miyauchi T, Maeda S, Sakai S, Fujii N, Miyazaki H, Kakinuma Y, Matsuda M, Yamaguchi I. Cardiac hypertrophy by hypertension and exercise training exhibits different gene expression of enzymes in energy metabolism. Hypertens Res 26: 829-837, 2003.
30. Lang CH, Bagby GJ, Buday AZ, Spitzer JJ. The contribution of gluconeogenesis to glycogen repletion during glucose infusion in endotoxemia. Metabolism 36: 180-187, 1987.
31. Lissandron V, Zaccolo M. Compartmentalized cAMP/PKA signalling regulates cardiac excitation-contraction coupling. J Muscle Res Cell Motil 27: 399-403, 2006.
32. Luiken JJ, Willems J, Coort SL, Coumans WA, Bonen A, Van Der Vusse GJ, Glatz JF. Effects of cAMP modulators on long-chain fatty-acid uptake and utilization by electrically stimulated rat cardiac myocytes. Biochem J 367: 881-887, 2002.
33. Mcmahon EG, Wennin GQ, Goellner J, Rudolph AE. Cardiac-specific 11 beta hydroxysteroid dehydrogenase type 2 transgenic mice. edited by CORP P. US: 2004.
34. Mitchell S, Ota A, Foster W, Zhang B, Fang Z, Patel S, Nelson SF, Horvath S, Wang Y. Distinct gene expression profiles in adult mouse heart following targeted MAP kinase activation. Physiol Genomics 25: 50-59, 2006.
35. Miyamoto T, Takeishi Y, Tazawa S, Inoue M, Aoyama T, Takahashi H, Arimoto T, Shishido T, Tomoike H, Kubota I. Fatty acid metabolism assessed by 125I-iodophenyl 9-methylpentadecanoic acid (9MPA) and expression of fatty acid utilization enzymes in volume-overloaded hearts. Eur J Clin Invest 34: 176-181, 2004.
36. Movsesian MA, Bristow MR. Alterations in cAMP-mediated signaling and their role in the pathophysiology of dilated cardiomyopathy. Curr Top Dev Biol 68: 25-48, 2005.
37. Nielsen LB, Veniant M, Boren J, Raabe M, Wong JS, Tam C, Flynn L, Vanni-Reyes T, Gunn MD, Goldberg IJ, Hamilton RL, Young SG. Genes for apolipoprotein B and microsomal triglyceride transfer protein are expressed in the heart: evidence that the heart has the capacity to synthesize and secrete lipoproteins. Circulation 98: 13-16, 1998.
38. Odley A, Hahn HS, Lynch RA, Marreez Y, Osinska H, Robbins J, Dorn GW 2nd. Regulation of cardiac contractility by Rab4-modulated beta2-adrenergic receptor recycling. Proc Natl Acad Sci USA 101: 7082-7087, 2004.
39. Park TS, Yamashita H, Blaner WS, Goldberg IJ. Lipids in the heart: a source of fuel and a source of toxins. Curr Opin Lipidol 18: 277-282, 2007.
40. Parton RG, Way M, Zorzi N, Stang E. Caveolin-3 associates with developing T-tubules during muscle differentiation. J Cell Biol 136: 137-154, 1997.
41. Ratajczak P, Oliviero P, Marotte F, Kolar F, Ostadal B, Samuel JL. Expression and localization of caveolins during postnatal development in rat heart: implication of thyroid hormone. J Appl Physiol 99: 244-251, 2005.
42. Rybin VO, Xu X, Lisanti MP, Steinberg SF. Differential targeting of beta-adrenergic receptor subtypes and adenylyl cyclase to cardiomyocyte caveolae. A mechanism to functionally regulate the cAMP signaling pathway. J Biol Chem 275: 41447-41457, 2000.
43. Song KS, Scherer PE, Tang Z, Okamoto T, Li S, Chafel M, Chu C, Kohtz DS, Lisanti MP. Expression of caveolin-3 in skeletal, cardiac, and smooth muscle cells. Caveolin-3 is a component of the sarcolemma and co-fractionates with dystrophin and dystrophin-associated glycoproteins. J Biol Chem 271: 15160-15165, 1996.
44. Toya Y, Schwencke C, Couet J, Lisanti MP, Ishikawa Y. Inhibition of adenylyl cyclase by caveolin peptides. Endocrinology 139: 2025-2031, 1998.
45. van der Sluijs P, Hull M, Webster P, Male P, Goud B, Mellman I. The small GTP-binding protein rab4 controls an early sorting event on the endocytic pathway. Cell 70: 729-740, 1992.
46. van der Vusse GJ, Glatz JF, Stam HC, Reneman RS. Fatty acid homeostasis in the normoxic and ischemic heart. Physiol Rev 72: 881-940, 1992.
47. van der Vusse GJ, van Bilsen M, Glatz JF. Cardiac fatty acid uptake and transport in health and disease. Cardiovasc Res 45: 279-293, 2000.
48. van Vlijmen BJ, Rohlmann A, Page ST, Bensadoun A, Bos IS, van Berkel TJ, Havekes LM, Herz J. An extrahepatic receptor-associated protein-sensitive mechanism is involved in the metabolism of triglyceride-rich lipoproteins. J Biol Chem 274: 35219-35226, 1999.
49. Vistisen B, Roepstorff K, Roepstorff C, Bonen A, van Deurs B, Kiens B. Sarcolemmal FAT/CD36 in human skeletal muscle colocalizes with caveolin-3 and is more abundant in type 1 than in type 2 fibers. J Lipid Res 45: 603-609, 2004.
50. Woodman SE, Park DS, Cohen AW, Cheung MW, Chandra M, Shirani J, Tang B, Jelicks LA, Kitsis RN, Christ GJ, Factor SM, Tanowitz HB, Lisanti MP. Caveolin-3 knock-out mice develop a progressive cardiomyopathy and show hyperactivation of the p42/44 MAPK cascade. J Biol Chem 277: 38988-38997, 2002.
51. Yokoi Y, Horiguchi Y, Araki M, Motojima K. Regulated expression by PPARalpha and unique localization of 17beta-hydroxysteroid dehydrogenase type 11 protein in mouse intestine and liver. FEBS J 274: 4837-4847, 2007.
52. Yokoyama M, Yagyu H, Hu Y, Seo T, Hirata K, Homma S, Goldberg IJ. Apolipoprotein B production reduces lipotoxic cardiomyopathy: studies in heart-specific lipoprotein lipase transgenic mouse. J Biol Chem 279: 4204-4211, 2004.